Dimolegin® (60 mg) for Patients With Moderate COVID-19: A Non-Interventional Study
Clinical trial NCT07134738 · COMPLETED
Trial details
- NCT number
- NCT07134738
- Sponsor
- Avexima Diol LLC
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-06-07
- Primary completion
- 2025-01-15
- Enrollment
- 184
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.